We are a law firm dedicated to helping those injured by Medtronic Sprint Fidelis Defibrillator Lead.
Medtronic Recall Lawsuit
- Sprint Fidelis Lawsuit Status | Medtronic Recalls Heart Leads
- Medtronic Lead Recall Testimony | Sprint Fidelis News
- Medtronic Recall Lawsuit | Sprint Fidelis Defective Lead Attorney Lawyer
- Medtronic Heart Lead Recall | Class Action Lawsuit
- Sprint Fidelis Lead Recall 6930 Medtronic Lawsuit
- 6931 Medtronic Sprint Fidelis lead recall class action lawsuit
- Medtronic 6948 lead recall class action lawsuits
Defective Defibrillator Lead
The Medtronic Sprint Fidelis leads were pulled from the market in October 2007 
because fractures had been detected in some wires. There are approximately 268,000 Medtronic leads implanted in patients worldwide. Medtronic’s Sprint Fidelis defibrillation leads were recalled following the reporting of major complications and the death of several heart patients.
Patients have experienced complications as a result of defective leads such as unnecessary shocks or jolts or not operating at all. In their October 15, 2007 letter to patients, Medtronic states that patients with a Sprint Fidelis lead “…are more likely to experience complications from removal than from a problem with a Sprint Fidelis lead”. This puts patients who have experienced problems or side effects in the difficult position of deciding whether to have the Medtronic leads removed or risk potential problems. There is currently no test that will predict if a Medtronic lead will fracture. The FDA advises that defibrillator settings be adjusted so that potential fractures can more easily be detected in patients.
Implantable cardioverter defibrillators (ICDs) and Cardiac Resynchronization Therapy-Defibrillators (CRT-Ds) are used to treat abnormal heart rhythms that can cause the heart to suddenly stop. Implanted defibrillators shock the heart back into normal rhythm by sending an energy pulse through an electronic lead (wire) that is connected to the patient’s heart.
If you or a loved one has been injured by a defective Medtronic defibrillator lead please contact us for a free consultation and case review. A Medtronic class action lead attorney can go over your legal rights and options and evaluate any potential claims you may have. You may be entitled to compensation and we can help.
U.S. Food & Drug Administration Statement On Medtronic Sprint Fidelis Defibrillator
Medtronic Suspends Sprint Fidelis Defibrillation Leads (PDF)
U.S. FDA Class 1 Recall Report
If you or a loved one have been injured by the Medtronic Sprint Fidelis lead please contact us immediately. You may be entitled to compensation.
Following the Medtronic recall of their Sprint Fidelis leads the Food and Drug Administration (FDA) has been involved keeping patients informed of new information regarding the defective leads as it becomes available. The following Question and Answer sheet was released by the FDA to help consumers affected by the Medtronic lead recall.
Medtronic Recalls Sprint Fidelis […]
On June 11, 2008 Bridget Robb testified before the Senate Judiciary Committee regarding her experience with the Medtronic lead recall. Ms. Robb suffered 31 shocks as a result of a defective Sprint Fidelis lead manufactured by Medtronic. Ms. Robb tells her story and shows how important it is for manufacturers of dangerous and defective products to […]
Following the Medtronic recall of their Sprint Fidelis heart leads the FDA released a statement covering the background of the Medtronic leads and recommendations.
Neither the FDA, Medtronic, nor representatives of the Heart Rhythm Society, recommend the routine surgical removal of a fractured lead because removal carries risks. Instead, physicians should weigh the benefits and risks […]
On October 15, 2007, Medtronic, Inc. announced that it was recalling its Sprint Fidelis defibrillation leads. Medtronic announced that the recall was due to “the potential for lead fractures.” At the time of the recall, there were reports of at least five deaths associated with the defibrillator leads. The Food and Drug Administration classified the […]
As of October 2007, Medtronic was aware of at least 665 chronic fractures in returned Sprint Fidelis leads. The majority of these fractures (approximately 90%) have occurred in the anode or cathode conductors. The Medtronic Sprint Fidelis 6930 lead was included in the 2007 recall. There seems to be evidence that Medtronic has knowledge their […]
